Archive for May 2023

The Connecticut-based bank plans to open its first out of state, full-service branch in the fall. Read More

Citizens Bank, the state’s second-largest bank, will pay a $9 million civil penalty to resolve allegations that the bank failed to manage and respond to customers’ credit card disputes and fraud claims, the Consumer Financial Protection Bureau (CFPB) announced Monday. Read More

With a full approval of a new Alzheimer’s drug likely on the horizon, patient advocates are making the case that Medicare coverage should extend beyond clinical trials. Read More

First Citizens is accusing HSBC of orchestrating the mass resignations of dozens of former Silicon Valley Bank employees, including some based in Boston, to launch a competing venture banking unit. Read More

Good morning, Boston. Happy National Taffy Day (it’s also National Lucky Penny Day, which might help you buy a piece of taffy). Here are the five things you need to know in Boston business news to start your workday. Read More

ClearMotion announced this morning that it has secured a significant production order from an EV automaker. Read More

Catherine Sabatos-Peyton’s last startup was only in operation for about a year before Novartis AG scooped it up for a cool $248 million. Now, after about five years continuing the work of that startup — cancer firm CoStim Pharmaceuticals — inside of Novartis, including as executive director and head of immune modulation, Sabatos-Peyton is striking…

ReNAgade Therapeutics is emerging from stealth with a leadership team hailing from Alnylam Pharmaceuticals and Moderna. The company has about 100 employees already. Its headquarters is 640 Memorial Drive in Cambridge, a storied building that’s been home to a Ford Motor Co. (NYSE: F) assembly plant, a Polaroid Corp. manufacturing facility and MIT. Read More

Seafreeze Shoreside, a Port Judith squid processor, is backed by lawyers for a libertarian Texas think tank. Vineyard Wind says a court-ordered pause would likely tank the project. Read More

As opioid overdose deaths remain high across the state, substance abuse treatment providers say that increasing reimbursement rates for Medicaid patients may be necessary to avoid closing available beds at addiction and recovery facilities. Read More